Antimicrob Agents Chemother

1. GOMIS-FONT MA, Pitart C, Del Barrio-Tofino E, Zboromyrska Y, et al
   Emergence of Resistance to Novel Cephalosporin-beta-Lactamase Inhibitor Combinations through the Modification of the Pseudomonas aeruginosa MexCD-OprJ Efflux Pump.
   Antimicrob Agents Chemother. 2021;65:e0008921.
   

   >> Share

   
   
2. LIMONTA D, Dyna-Dagman L, Branton W, Mancinelli V, et al
   Nodosome Inhibition as a Novel Broad-Spectrum Antiviral Strategy against Arboviruses, Enteroviruses, and SARS-CoV-2.
   Antimicrob Agents Chemother. 2021;65:e0049121.
   

   >> Share

   
   
3. WU X, Li N, Wang G, Liu W, et al
   Tolerability, Safety, Pharmacokinetics, and Immunogenicity of a Novel SARS-CoV-2 Neutralizing Antibody, Etesevimab, in Chinese Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, First-in-Human Phase 1 Study.
   Antimicrob Agents Chemother. 2021;65:e0035021.
   

   >> Share

   
   

   
   Antiviral Res

4. DO TND, Donckers K, Vangeel L, Chatterjee AK, et al
   A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents.
   Antiviral Res. 2021 Jun 26:105122. doi: 10.1016/j.antiviral.2021.105122.
   

   >> Share

   
   
5. KASHYAP T, Murray J, Walker CJ, Chang H, et al
   Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo.
   Antiviral Res. 2021 Jun 19:105115. doi: 10.1016/j.antiviral.2021.105115.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

6. ZHAO L, Hao Y, Song Z, Fan Y, et al
   TRIM37 negatively regulates inflammatory responses induced by virus infection via controlling TRAF6 ubiquitination.
   Biochem Biophys Res Commun. 2021;556:87-92.
   

   >> Share

   
   
7. JIN D, Wei J, Sun J
   Analysis of the molecular mechanism of SARS-CoV-2 antibodies.
   Biochem Biophys Res Commun. 2021;566:45-52.
   

   >> Share

   
   
8. RYU DK, Song R, Kim M, Kim YI, et al
   Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant.
   Biochem Biophys Res Commun. 2021;566:135-140.
   

   >> Share

   
   

   
   Biochemistry

9. ALLEN JD, Chawla H, Samsudin F, Zuzic L, et al
   Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation.
   Biochemistry. 2021;60:2153-2169.
   

   >> Share

   
   

   
   BMJ

10. NABAVI N
    Open your mind without leaving your sofa.
    BMJ. 2021;374:n1715.
    

    >> Share

    
    
11. KAMINSKAITE V
    Covid-19: Looking back at the experiences of graduates and educators during the interim Foundation Year 1.
    BMJ. 2021;374:n1265.
    

    >> Share

    
    
12. WILKINSON D, Finlay I, Pollard AJ, Forsberg L, et al
    Should we delay covid-19 vaccination in children?
    BMJ. 2021;374:n1687.
    

    >> Share

    
    
13. MITCHELL S, Chapman H, Fowler I, McTague L, et al
    Dying at home during covid-19: a view from primary care.
    BMJ. 2021;374:n1776.
    

    >> Share

    
    

    
    Drugs

14. ROE MT, Patrick-Lake B, von Eschenbach AC
    Post-COVID-19 Syndrome: Leveraging the Patient Perspective and Technological Innovations to Enable the Delineation of Effective Treatments.
    Drugs. 2021;81:1235-1237.
    

    >> Share

    
    

    
    J Clin Microbiol

15. JIA HL, Li P, Liu HJ, Zhong JY, et al
    Genomic Elucidation of a COVID-19 Resurgence and Local Transmission of SARS-CoV-2 in Guangzhou, China.
    J Clin Microbiol. 2021;59:e0007921.
    

    >> Share

    
    
16. KRONE M, Gutling J, Wagener J, Lam TT, et al
    Performance of Three SARS-CoV-2 Immunoassays, Three Rapid Lateral Flow Tests, and a Novel Bead-Based Affinity Surrogate Test for the Detection of SARS-CoV-2 Antibodies in Human Serum.
    J Clin Microbiol. 2021;59:e0031921.
    

    >> Share

    
    
17. RHOADS DD, Plunkett D, Nakitandwe J, Dempsey A, et al
    Endemic SARS-CoV-2 Polymorphisms Can Cause a Higher Diagnostic Target Failure Rate than Estimated by Aggregate Global Sequencing Data.
    J Clin Microbiol. 2021;59:e0091321.
    

    >> Share

    
    
18. CHANDLER CM, Bourassa L, Mathias PC, Greninger AL, et al
    Estimating the False-Positive Rate of Highly Automated SARS-CoV-2 Nucleic Acid Amplification Testing.
    J Clin Microbiol. 2021;59:e0108021.
    

    >> Share

    
    
19. WANG H, Jean S, Eltringham R, Madison J, et al
    Mutation-Specific SARS-CoV-2 PCR Screen: Rapid and Accurate Detection of Variants of Concern and the Identification of a Newly Emerging Variant with Spike L452R Mutation.
    J Clin Microbiol. 2021;59:e0092621.
    

    >> Share

    
    
20. WANG H, Miller JA, Verghese M, Sibai M, et al
    Multiplex SARS-CoV-2 Genotyping Reverse Transcriptase PCR for Population-Level Variant Screening and Epidemiologic Surveillance.
    J Clin Microbiol. 2021;59:e0085921.
    

    >> Share

    
    
21. NIELSEN MC, Reynoso D, Ren P
    The Brief Case: A Fatal Case of SARS-CoV-2 Coinfection with Coccidioides in Texas-Another Challenge We Face.
    J Clin Microbiol. 2021;59:e0016321.
    

    >> Share

    
    
22. NIELSEN MC, Reynoso D, Ren P
    Closing the Brief Case: A Fatal Case of SARS-CoV-2 Coinfection with Coccidioides in Texas-Another Challenge We Face.
    J Clin Microbiol. 2021;59:e0016421.
    

    >> Share

    
    

    
    J Infect Dis

23. PETRIE JG, Bazzi LA, McDermott AB, Follmann D, et al
    Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
    J Infect Dis. 2021;224:49-59.
    

    >> Share

    
    
24. KANG CK, Kim M, Lee S, Kim G, et al
    Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Infect Dis. 2021;224:39-48.
    

    >> Share

    
    
25. DEE K, Goldfarb DM, Haney J, Amat JAR, et al
    Human Rhinovirus Infection Blocks Severe Acute Respiratory Syndrome Coronavirus 2 Replication Within the Respiratory Epithelium: Implications for COVID-19 Epidemiology.
    J Infect Dis. 2021;224:31-38.
    

    >> Share

    
    
26. KRAAY ANM, Han P, Kambhampati AK, Wikswo ME, et al
    Impact of Nonpharmaceutical Interventions for Severe Acute Respiratory Syndrome Coronavirus 2 on Norovirus Outbreaks: An Analysis of Outbreaks Reported By 9 US States.
    J Infect Dis. 2021;224:9-13.
    

    >> Share

    
    
27. DILLNER J, Elfstrom KM, Blomqvist J, Engstrand L, et al
    High Amounts of SARS-CoV-2 Precede Sickness Among Asymptomatic Health Care Workers.
    J Infect Dis. 2021;224:14-20.
    

    >> Share

    
    
28. DA SILVA ANTUNES R, Pallikkuth S, Williams E, Dawen Yu E, et al
    Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers.
    J Infect Dis. 2021;224:70-80.
    

    >> Share

    
    
29. PATHELA P, Crawley A, Weiss D, Maldin B, et al
    Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Following the Largest Initial Epidemic Wave in the United States: Findings From New York City, 13 May to 21 July 2020.
    J Infect Dis. 2021;224:196-206.
    

    >> Share

    
    
30. PARROTT JC, Maleki AN, Vassor VE, Osahan S, et al
    Prevalence of SARS-CoV-2 Antibodies in New York City Adults, June-October 2020: A Population-Based Survey.
    J Infect Dis. 2021;224:188-195.
    

    >> Share

    
    
31. CASADO JL, Vizcarra P, Velasco H, Hammerle J, et al
    Progressive and Parallel Decline of Humoral and T-Cell Immunity in Convalescent Healthcare Workers with Asymptomatic or Mild-to-Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Infect Dis. 2021;224:241-245.
    

    >> Share

    
    
32. ROSENBERG ES, Tesoriero JM
    A Tale of Many New York Cities.
    J Infect Dis. 2021 Jun 4. pii: 6291934. doi: 10.1093.
    

    >> Share

    
    
33. PANDA AK, Pati A, Padhi S, Sahoo AK, et al
    Association of Granulin rs5848 (C>T) Polymorphism With Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Mortality Rate.
    J Infect Dis. 2021;224:366-367.
    

    >> Share

    
    
34. BERNAL E, Gimeno L, Alcaraz MJ, Quadeer AA, et al
    Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019.
    J Infect Dis. 2021;224:229-240.
    

    >> Share

    
    
35. JALKANEN P, Pasternack A, Maljanen S, Melen K, et al
    A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics.
    J Infect Dis. 2021;224:218-228.
    

    >> Share

    
    
36. VILLARINO E, Deng X, Kemper CA, Jorden MA, et al
    Introduction, Transmission Dynamics, and Fate of Early Severe Acute Respiratory Syndrome Coronavirus 2 Lineages in Santa Clara County, California.
    J Infect Dis. 2021;224:207-217.
    

    >> Share

    
    
37. SYED F, Li W, Relich RF, Russell PM, et al
    Excessive Matrix Metalloproteinase-1 and Hyperactivation of Endothelial Cells Occurred in COVID-19 Patients and Were Associated With the Severity of COVID-19.
    J Infect Dis. 2021;224:60-69.
    

    >> Share

    
    

    
    J Virol

38. YAN B, Chakravorty S, Mirabelli C, Wang L, et al
    Host-virus chimeric events in SARS-CoV2 infected cells are infrequent and artifactual.
    J Virol. 2021 May 12. pii: JVI.00294-21. doi: 10.1128/JVI.00294.
    

    >> Share

    
    
39. TRIBOLET L, Alexander MR, Brice AM, van Vuren PJ, et al
    ILRUN downregulates ACE2 expression and blocks infection of human cells by SARS-CoV-2.
    J Virol. 2021 May 7. pii: JVI.00327-21. doi: 10.1128/JVI.00327.
    

    >> Share

    
    
40. YANG J, Zhang P, Huang M, Qiao S, et al
    Key amino acids of M1-41 and M2-27 determine growth and pathogenicity of chimeric H17 bat influenza virus in cells and in mice.
    J Virol. 2021 Jul 21:JVI0101921. doi: 10.1128/JVI.01019.
    

    >> Share

    
    

    
    JAMA

41. BERTOLLINI R, Chemaitelly H, Yassine HM, Al-Thani MH, et al
    Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar.
    JAMA. 2021 Jun 9. pii: 2781112. doi: 10.1001/jama.2021.9970.
    

    >> Share

    
    
42. ABBASI J
    Artificial Intelligence in COVID-19 Imaging Mismatched to the Clinic.
    JAMA. 2021;326:124.
    

    >> Share

    
    

    
    Lancet

43. WENHAM C, Kavanagh M, Phelan A, Rushton S, et al
    Problems with traffic light approaches to public health emergencies of international concern.
    Lancet. 2021;397:1856-1858.
    

    >> Share

    
    
44. SIRLEAF EJ, Clark H
    Report of the Independent Panel for Pandemic Preparedness and Response: making COVID-19 the last pandemic.
    Lancet. 2021 May 11. pii: S0140-6736(21)01095.
    

    >> Share

    
    
45. SHROFF ZC, Marten R, Vega J, Peters DH, et al
    Time to reconceptualise health systems.
    Lancet. 2021;397:2145.
    

    >> Share

    
    
46. BEYRER C
    A pandemic anniversary: 40 years of HIV/AIDS.
    Lancet. 2021;397:2142-2143.
    

    >> Share

    
    
47. NNAJI CA, Ndwandwe D, Lesosky M, Mahomed H, et al
    Tackling missed opportunities for vaccination in a new era of immunisation.
    Lancet. 2021 Jun 2. pii: S0140-6736(21)01226.
    

    >> Share

    
    
48. ZAROCOSTAS J
    Aid agencies escalate Gaza relief effort.
    Lancet. 2021;397:2136.
    

    >> Share

    
    
49. BOLLYKY TJ, Murray CJL, Reiner RC Jr
    Epidemiology, not geopolitics, should guide COVID-19 vaccine donations.
    Lancet. 2021 Jun 8. pii: S0140-6736(21)01323.
    

    >> Share

    
    
50. BOROBIA AM, Carcas AJ, Perez-Olmeda M, Castano L, et al
    Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
    Lancet. 2021 Jun 25. pii: S0140-6736(21)01420.
    

    >> Share

    
    
51. SMITH MJ
    What constitutes success in the roll-out of COVID-19 vaccines?
    Lancet. 2021 Jun 25. pii: S0140-6736(21)01244.
    

    >> Share

    
    
52. THE LANCET
    Germany's election: transformation versus more of the same.
    Lancet. 2021;398:1.
    

    >> Share

    
    
53. DEVI S
    North Korean health at risk due to border closures.
    Lancet. 2021;398:13.
    

    >> Share

    
    
54. THE LANCET
    COVID-19 in Latin America-emergency and opportunity.
    Lancet. 2021;398:93.
    

    >> Share

    
    
55. THORNTON J
    Levelling up health in the UK.
    Lancet. 2021;398:14-15.
    

    >> Share

    
    
56. CLARKE R
    Sparks through the stubble: dying in a pandemic.
    Lancet. 2021;398:18-19.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

57. OLSEN SJ, Winn AK, Budd AP, Prill MM, et al
    Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic - United States, 2020-2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1013-1019.
    

    >> Share

    
    

    
    N Engl J Med

58. QUINN SC, Andrasik MP
    Addressing Vaccine Hesitancy in BIPOC Communities - Toward Trustworthiness, Partnership, and Reciprocity.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103104.
    

    >> Share

    
    
59. GOLDFARB JL, Kreps S, Brownstein JS, Kriner DL, et al
    Beyond the First Dose - Covid-19 Vaccine Follow-through and Continued Protective Measures.
    N Engl J Med. 2021 Apr 28. doi: 10.1056/NEJMp2104527.
    

    >> Share

    
    
60. ABU-RADDAD LJ, Chemaitelly H, Butt AA
    Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMc2104974.
    

    >> Share

    
    
61. FRENCK RW JR, Klein NP, Kitchin N, Gurtman A, et al
    Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
    N Engl J Med. 2021 May 27. doi: 10.1056/NEJMoa2107456.
    

    >> Share

    
    
62. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Monoclonal Antibodies and Vaccine Boosts.
    N Engl J Med. 2021;385:e18.
    

    >> Share

    
    
63. KRAUSE PR, Fleming TR, Longini IM, Peto R, et al
    SARS-CoV-2 Variants and Vaccines.
    N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMsr2105280.
    

    >> Share

    
    
64. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: How Well Are Covid-19 Vaccines Working?
    N Engl J Med. 2021;385:e15.
    

    >> Share

    
    

    
    PLoS Comput Biol

65. CAVALLARO M, Moiz H, Keeling MJ, McCarthy ND, et al
    Contrasting factors associated with COVID-19-related ICU admission and death outcomes in hospitalised patients by means of Shapley values.
    PLoS Comput Biol. 2021;17:e1009121.
    

    >> Share

    
    

    
    PLoS Med

66. MAO W, Ogbuoji O, Watkins D, Bharali I, et al
    Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.
    PLoS Med. 2021;18:e1003675.
    

    >> Share

    
    
67. KANDULA S, Shaman J
    Investigating associations between COVID-19 mortality and population-level health and socioeconomic indicators in the United States: A modeling study.
    PLoS Med. 2021;18:e1003693.
    

    >> Share

    
    

    
    PLoS One

68. GUTHRIE JL, Chen AJ, Budhram DR, Cronin K, et al
    Characteristics of SARS-CoV-2 testing for rapid diagnosis of COVID-19 during the initial stages of a global pandemic.
    PLoS One. 2021;16:e0253941.
    

    >> Share

    
    
69. KONTOS Z
    Efficacy of "Essential Iodine Drops" against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
    PLoS One. 2021;16:e0254341.
    

    >> Share

    
    
70. RAVINDRAN R, McReynolds C, Yang J, Hammock BD, et al
    Immune response dynamics in COVID-19 patients to SARS-CoV-2 and other human coronaviruses.
    PLoS One. 2021;16:e0254367.
    

    >> Share

    
    
71. JAAM M, Nazar Z, Rainkie DC, Hassan DA, et al
    Using Assessment Design Decision Framework in understanding the impact of rapid transition to remote education on student assessment in health-related colleges: A qualitative study.
    PLoS One. 2021;16:e0254444.
    

    >> Share

    
    
72. ROSE S, Hartnett J, Pillai S
    Healthcare worker's emotions, perceived stressors and coping mechanisms during the COVID-19 pandemic.
    PLoS One. 2021;16:e0254252.
    

    >> Share

    
    
73. GIBERTONI D, Reno C, Rucci P, Fantini MP, et al
    COVID-19 incidence and mortality in non-dialysis chronic kidney disease patients.
    PLoS One. 2021;16:e0254525.
    

    >> Share

    
    
74. RISTIC M, Milosavljevic B, Vapa S, Markovic M, et al
    Seroprevalence of antibodies against SARS-CoV-2 virus in Northern Serbia (Vojvodina): A four consecutive sentinel population-based survey study.
    PLoS One. 2021;16:e0254516.
    

    >> Share

    
    
75. DAVIS EJ, Amorim G, Dahn B, Moon TD, et al
    Perceived ability to comply with national COVID-19 mitigation strategies and their impact on household finances, food security, and mental well-being of medical and pharmacy students in Liberia.
    PLoS One. 2021;16:e0254446.
    

    >> Share

    
    
76. ELKIN ME, Zhu X
    Understanding and predicting COVID-19 clinical trial completion vs. cessation.
    PLoS One. 2021;16:e0253789.
    

    >> Share

    
    
77. BIENTZLE M, Eggeling M, Kanzleiter M, Thieme K, et al
    The impact of narrative writing on empathy, perspective-taking, and attitude: Two randomized controlled experiments on violations of Covid-19 protection regulations.
    PLoS One. 2021;16:e0254501.
    

    >> Share

    
    
78. AHMED MH, Kanfe SG, Jarso MH
    Intention to receive vaccine against COVID-19 and associated factors among health professionals working at public hospitals in resource limited settings.
    PLoS One. 2021;16:e0254391.
    

    >> Share

    
    
79. MENGES D, Ballouz T, Anagnostopoulos A, Aschmann HE, et al
    Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study.
    PLoS One. 2021;16:e0254523.
    

    >> Share

    
    
80. HOFFER-HAWLIK M, Moran A, Zerihun L, Usseglio J, et al
    Telemedicine interventions for hypertension management in low- and middle-income countries: A scoping review.
    PLoS One. 2021;16:e0254222.
    

    >> Share

    
    
81. B C UB, Pokharel S, Munikar S, Wagle CN, et al
    Anxiety and depression among people living in quarantine centers during COVID-19 pandemic: A mixed method study from western Nepal.
    PLoS One. 2021;16:e0254126.
    

    >> Share

    
    
82. PADROS-CUXART M, Rodrigues de Mello R, Ramis-Salas M, Duque E, et al
    Dialogic gathering of films. Promoting meaningful online interactions during COVID-19 confinement.
    PLoS One. 2021;16:e0254132.
    

    >> Share

    
    
83. GUARACHA-BASANEZ GA, Contreras-Yanez I, Hernandez-Molina G, Gonzalez-Marin A, et al
    Clinical and bioethical implications of health care interruption during the COVID-19 pandemic: A cross-sectional study in outpatients with rheumatic diseases.
    PLoS One. 2021;16:e0253718.
    

    >> Share

    
    
84. RIDEOUT A, Murray C, Isles C
    Regional variation in COVID-19 positive hospitalisation across Scotland during the first wave of the pandemic and its relation to population density: A cross-sectional observation study.
    PLoS One. 2021;16:e0253636.
    

    >> Share

    
    
85. NGUYEN NT, Chinn J, De Ferrante M, Kirby KA, et al
    Male gender is a predictor of higher mortality in hospitalized adults with COVID-19.
    PLoS One. 2021;16:e0254066.
    

    >> Share

    
    
86. KAZEMIAN S, Fuller S, Algara C
    The role of race and scientific trust on support for COVID-19 social distancing measures in the United States.
    PLoS One. 2021;16:e0254127.
    

    >> Share

    
    
87. HALE T, Angrist N, Hale AJ, Kira B, et al
    Government responses and COVID-19 deaths: Global evidence across multiple pandemic waves.
    PLoS One. 2021;16:e0253116.
    

    >> Share

    
    
88. LIN Y, Peng F
    Control strategies against COVID-19 in China: Significance of effective testing in the long run.
    PLoS One. 2021;16:e0253901.
    

    >> Share

    
    
89. COSTA DE ASSIS SJ, Lopes JM, de Lima Filho BF, Jose Bouzas Sanchis G, et al
    Dissemination of COVID-19 in inland cities of Northeastern Brazil.
    PLoS One. 2021;16:e0253171.
    

    >> Share

    
    
90. MAASKANT A, Meijer L, Fagrouch Z, Bakker J, et al
    Bronchoalveolar lavage affects thorax computed tomography of healthy and SARS-CoV-2 infected rhesus macaques (Macaca mulatta).
    PLoS One. 2021;16:e0252941.
    

    >> Share

    
    
91. STVERAKOVA T, Jacisko J, Busch A, Safarova M, et al
    The impact of COVID-19 on Physical Activity of Czech children.
    PLoS One. 2021;16:e0254244.
    

    >> Share

    
    
92. BATHINA KC, Ten Thij M, Valdez D, Rutter LA, et al
    Declining well-being during the COVID-19 pandemic reveals US social inequities.
    PLoS One. 2021;16:e0254114.
    

    >> Share

    
    
93. JARRETT BA, Peitzmeier SM, Restar A, Adamson T, et al
    Gender-affirming care, mental health, and economic stability in the time of COVID-19: A multi-national, cross-sectional study of transgender and nonbinary people.
    PLoS One. 2021;16:e0254215.
    

    >> Share

    
    
94. SPOUGE JL
    A comprehensive estimation of country-level basic reproduction numbers R0 for COVID-19: Regime regression can automatically estimate the end of the exponential phase in epidemic data.
    PLoS One. 2021;16:e0254145.
    

    >> Share

    
    
95. BERNACER J, Garcia-Manglano J, Camina E, Guell F, et al
    Polarization of beliefs as a consequence of the COVID-19 pandemic: The case of Spain.
    PLoS One. 2021;16:e0254511.
    

    >> Share

    
    
96. CHORAZKA M, Flury D, Herzog K, Albrich WC, et al
    Clinical outcomes of adults hospitalized for laboratory confirmed respiratory syncytial virus or influenza virus infection.
    PLoS One. 2021;16:e0253161.
    

    >> Share

    
    
97. NORRULASHIKIN MA, Yusof F, Hanafiah NHM, Norrulashikin SM, et al
    Modelling monthly influenza cases in Malaysia.
    PLoS One. 2021;16:e0254137.
    

    >> Share

    
    
98. DE LA CRUZ JA, Ganesh T, Diebold BA, Cao W, et al
    Quinazolin-derived myeloperoxidase inhibitor suppresses influenza A virus-induced reactive oxygen species, pro-inflammatory mediators and improves cell survival.
    PLoS One. 2021;16:e0254632.
    

    >> Share

    
    
99. AMMANN J, Casagrande M
    Food disgust sensitivity predicts disease-preventing behaviour beyond the food domain in the COVID-19 pandemic in Germany.
    PLoS One. 2021;16:e0254648.
    

    >> Share

    
    
100. DAVIS G, York AJ, Bacon WC, Lin SC, et al
     Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020.
     PLoS One. 2021;16:e0254667.
     

     >> Share

     
     
101. MONTELONGO A, Becker JL, Roman R, de Oliveira EB, et al
     The management of COVID-19 cases through telemedicine in Brazil.
     PLoS One. 2021;16:e0254339.
     

     >> Share

     
     
102. KITTIKRAISAK W, Piyaraj P, Vachiraphan A, Wongrapee T, et al
     Sero-surveillance for SARS-CoV-2 infection among healthcare providers in four hospitals in Thailand one year after the first community outbreak.
     PLoS One. 2021;16:e0254563.
     

     >> Share

     
     
103. ALAGOZ O, Sethi AK, Patterson BW, Churpek M, et al
     The impact of vaccination to control COVID-19 burden in the United States: A simulation modeling approach.
     PLoS One. 2021;16:e0254456.
     

     >> Share

     
     
104. AREF HM, Shokri H, Roushdy TM, Fathalla F, et al
     Pre-hospital causes for delayed arrival in acute ischemic stroke before and during the COVID-19 pandemic: A study at two stroke centers in Egypt.
     PLoS One. 2021;16:e0254228.
     

     >> Share

     
     
105. LI L, Erfani A, Wang Y, Cui Q, et al
     Anatomy into the battle of supporting or opposing reopening amid the COVID-19 pandemic on Twitter: A temporal and spatial analysis.
     PLoS One. 2021;16:e0254359.
     

     >> Share

     
     
106. LEONI MLG, Lombardelli L, Colombi D, Bignami EG, et al
     Prediction of 28-day mortality in critically ill patients with COVID-19: Development and internal validation of a clinical prediction model.
     PLoS One. 2021;16:e0254550.
     

     >> Share

     
     
107. MIKI S, Sasaki H, Horiuchi H, Miyata N, et al
     On-admission SARS-CoV-2 RNAemia as a single potent predictive marker of critical condition development and mortality in COVID-19.
     PLoS One. 2021;16:e0254640.
     

     >> Share

     
     
108. CATANO-CORREA JC, Cardona-Arias JA, Porras Mancilla JP, Garcia MT, et al
     Bacterial superinfection in adults with COVID-19 hospitalized in two clinics in Medellin-Colombia, 2020.
     PLoS One. 2021;16:e0254671.
     

     >> Share

     
     
109. DIAZ F, Henriquez PA
     Social sentiment segregation: Evidence from Twitter and Google Trends in Chile during the COVID-19 dynamic quarantine strategy.
     PLoS One. 2021;16:e0254638.
     

     >> Share

     
     
110. PERRY BL, Aronson B, Railey AF, Ludema C, et al
     If you build it, will they come? Social, economic, and psychological determinants of COVID-19 testing decisions.
     PLoS One. 2021;16:e0252658.
     

     >> Share

     
     

     
     Proc Natl Acad Sci U S A

111. JELLIFFE E, Pangburn P, Pichler S, Ziebarth NR, et al
     Awareness and use of (emergency) sick leave: US employees' unaddressed sick leave needs in a global pandemic.
     Proc Natl Acad Sci U S A. 2021;118.
     

     >> Share

     
     
112. DE LIMA LF, Ferreira AL, Torres MDT, de Araujo WR, et al
     Minute-scale detection of SARS-CoV-2 using a low-cost biosensor composed of pencil graphite electrodes.
     Proc Natl Acad Sci U S A. 2021;118.
     

     >> Share

     
     
113. STAQUICINI DI, Tang FHF, Markosian C, Yao VJ, et al
     Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.
     Proc Natl Acad Sci U S A. 2021;118.
     

     >> Share

     
     
114. JANG WD, Jeon S, Kim S, Lee SY, et al
     Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay.
     Proc Natl Acad Sci U S A. 2021;118.
     

     >> Share

     
     
115. RUDIGER S, Konigorski S, Rakowski A, Edelman JA, et al
     Predicting the SARS-CoV-2 effective reproduction number using bulk contact data from mobile phones.
     Proc Natl Acad Sci U S A. 2021;118.
     

     >> Share

     
     

     
     Vaccine

116. DESAI AP, Desai AP, Loomis GJ
     Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration.
     Vaccine. 2021 Jun 23. pii: S0264-410X(21)00808.
     

     >> Share

     
     
117. MYLES IA, Vinciguerra JS, Premus RT
     Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site.
     Vaccine. 2021 Jun 25. pii: S0264-410X(21)00811.
     

     >> Share

     
     
118. BALDOLLI A, Michon J, Appia F, Galimard C, et al
     Tolerance of BNT162b2 mRNA COVI-19 vaccine in patients with a medical history of COVID-19 disease: A case control study.
     Vaccine. 2021 Jun 23. pii: S0264-410X(21)00804.
     

     >> Share

     
     
119. LUNDBERG L, Bygdell M, Stukat von Feilitzen G, Woxenius S, et al
     Recent MMR vaccination in health care workers and Covid-19: A test negative case-control study.
     Vaccine. 2021 Jun 22. pii: S0264-410X(21)00795.
     

     >> Share

     
     
120. SCHEIBLHOFER S, Drothler S, Braun W, Braun R, et al
     Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding.
     Vaccine. 2021;39:4399-4403.
     

     >> Share

     
     
121. EARLE KA, Ambrosino DM, Fiore-Gartland A, Goldblatt D, et al
     Evidence for antibody as a protective correlate for COVID-19 vaccines.
     Vaccine. 2021 May 24. pii: S0264-410X(21)00658.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share